Stockreport

Aptorum Group Commences Commercialization of Dioscorea Opposita Bioactive Nutraceutical Tablets and Signed Sales Distribution Agreement in Hong Kong

Aptorum Group Limited - Class A Ordinary Shares  (APM) 
PDF NEW YORK--(BUSINESS WIRE)--Aptorum Group Limited (“Aptorum Group”), a pharmaceutical company focused on the development of novel therapeutics to address global unmet [Read more]